NEWS Recap (July 3) Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment
Autonomix Medical (NASDAQ: AMIX) shared preliminary positive results from its proof-of-concept human clinical trial targeting pancreatic cancer pain. In a recent Virtual Investor segment, Dr. Robert Schwartz detailed the results from the first five lead-in patients and discussed the advancements in pain management techniques with fewer side effects. The trial focuses on the safety and effectiveness of transvascular energy delivery to ablate nerves causing pain. Early indications suggest significant improvements in patient quality of life. For further details, the company has made patient testimonials and the segment available online.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment